Eksempler på brug af Common adverse events på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Official
-
Colloquial
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
All other common adverse events resolved in the majority of patients.
Angioedema, urticaria, rash,rarely- anaphylactic reactions are common adverse events that may trigger the vaccine Pneumo 23.
The most common adverse events should include disorders of the digestive system.
Headaches(some severe), peripheral oedema, andanaemias were the most common adverse events reported in these patients, none of which were considered serious.
Common adverse events: urinary tract disorders cystitis, urinary incontinence, urinary retention.
In general, the type and frequency of adverse events reported in patients with low body weight(≤ 60 kg) were similar to those of patients with higher weight(> 60 kg); however, the placebo- corrected frequencies of the following common adverse events were higher in low body weight than heavier patients: nausea(14% versus 2%), vomiting(6% versus 1%), and hypotension 4% versus 2.
Common adverse events considered to be related to raloxifene therapy were hot flashes and leg cramps.
A detailed assessment of the most common adverse events in the target population(IRLS baseline score 24-40 points) has been provided.
Very common adverse events for both diseases include headache, nasopharyngitis and upper respiratory tract infections.
If we consider the most common adverse events, the occurrence of which may be caused by taking this anti-ulcer drug, it should first select vomiting, nausea and diarrhea.
Common adverse events which led to treatment discontinuation of bortezomib and Caelyx included PPE, neuralgia, peripheral neuropathy, peripheral sensory neuropathy, thrombocytopaenia, decreased ejection fraction, and fatigue.
Restless Legs Syndrome, most common adverse events The most commonly(≥ 5%) reported adverse drug reactions in patients with Restless Legs Syndrome treated with SIFROL were nausea, headache, dizziness and fatigue.
Other less common adverse events(between 1 and 10 patients out of 100 treated) reported in association with interferon beta include diarrhoea, loss of appetite, vomiting, sleeping difficulty, dizziness, nervousness, itching, rash, nettle-rash, hair loss, dilatation of the blood vessels and palpitation, irregularities and/or changes in menstrual flow and serious reactions of the skin and mucous membranes.
The most common adverse events leading to withdrawal for BYETTA-treated patients were nausea(4% of patients) and vomiting 1.
The most common adverse events consisted of nausea and diarrhoea, which were generally reported at the beginning of treatment with no noticeable difference between groups afterwards.
The most common adverse events were transient local reactions(pain, redness, swelling at the injection site) and systemic reactions loss of appetite, fever, drowsiness, irritability.
The three most common adverse events reported were flu-like symptoms(cold,common cold, influenza, upper respiratory infection, etc.), pruritus and skin burning.
The most common adverse events with at least a possible relation to telbivudine were grade 3/ 4 blood creatine kinase elevations(6.8%), fatigue(4.4%), headache(3.0%) and nausea 2.6.
Other less common adverse events(between 1 and 10 patients out of 100 treated) reported in association with interferon beta include diarrhoea, loss of appetite, vomiting, sleeping difficulty, dizziness, nervousness, itching, rash, nettle-rash, hair loss, dilatation of the blood vessels and palpitation, irregularities and/or changes in menstrual flow and serious reactions of the skin and mucous membranes.
The most common adverse event was headache of mild to moderate intensity.
Health-care-associated infections are a specific example of a very common adverse event.
However, dizziness has been reported as a very common adverse event, and patients suffering from dizziness should not drive or operate machinery.
The most common adverse event associated with Kaletra therapy was diarrhoea and was generally of mild to moderate severity.
In controlled clinical trials for essential hypertension, hypertensive patients with left ventricular hypertrophy, chronic heart failure as well as for hypertension and type 2 diabetes mellitus with renal disease,the most common adverse event was dizziness.
Common Non-haematological Adverse Events Reported in≥ 10% of Patients, by Study Treatment.
In postmarketing spontaneous reporting, infections are the most common serious adverse event.